Virginia House Bill HB1922

Virginia 2023 Regular Session

• Introduced: 1/10/23
• Refer: 1/10/23

Caption

Delta-8 tetrahydrocannabinol; distribution, penalty.

Impact

If enacted, HB1922 would amend existing laws by specifically addressing delta-8 THC, which falls into a regulatory gray area distinct from delta-9 THC, the more commonly known psychoactive component of cannabis. This change would contribute to the state-level framework surrounding cannabinoid products, bringing delta-8 under stricter controls similar to those that govern traditional marijuana products. Consequently, the bill aims to enhance public safety and reduce potential abuse of delta-8 products.

Summary

House Bill 1922 aims to regulate the sale, distribution, and possession of delta-8 tetrahydrocannabinol (THC), a cannabinoid derived from hemp that has gained popularity due to its psychoactive effects. The bill proposes that it is unlawful for any individual to sell, distribute, or possess with the intent to sell delta-8 THC unless authorized by the existing Drug Control Act. Violators of this regulation would be guilty of a Class 1 misdemeanor, indicating a serious legal penalty aligned with traditional drug laws.

Contention

The bill has been met with mixed reactions among lawmakers and the public. Proponents argue that regulating delta-8 is necessary to ensure consumer safety, as the absence of regulations previously has led to untested and potentially dangerous products flooding the market. Conversely, opponents believe that strict regulation could limit access for legitimate consumers who use delta-8 for medicinal purposes or personal enjoyment. Furthermore, there are concerns that classifying delta-8 THC similarly to more harmful substances may unnecessarily criminalize a substance that some advocate as safer and less potent than other cannabinoids.